Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 82

    1.

    Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.

    Park B, Sung B, Yadav VR, Chaturvedi MM, Aggarwal BB.

    Biochem Pharmacol. 2011 Nov 1;82(9):1134-44. Epub 2011 Jul 27.

    PMID:
    21820422
    [PubMed - indexed for MEDLINE]
    2.

    Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients.

    Milojkovic D, Apperley JF, Gerrard G, Ibrahim AR, Szydlo R, Bua M, Reid A, Rezvani K, Foroni L, Goldman J, Marin D.

    Blood. 2012 Feb 23;119(8):1838-43. Epub 2011 Dec 14.

    PMID:
    22174159
    [PubMed - indexed for MEDLINE]
    3.

    Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.

    Hwang KK, Chen X, Kozink DM, Gustilo M, Marshall DJ, Whitesides JF, Liao HX, Catera R, Chu CC, Yan XJ, Luftig MA, Haynes BF, Chiorazzi N.

    Blood. 2012 Feb 16;119(7):e35-44. Epub 2011 Dec 12.

    PMID:
    22160618
    [PubMed - indexed for MEDLINE]
    4.

    Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

    Kantarjian HM, Shah NP, Cortes JE, Baccarani M, Agarwal MB, Undurraga MS, Wang J, Ipiña JJ, Kim DW, Ogura M, Pavlovsky C, Junghanss C, Milone JH, Nicolini FE, Robak T, Van Droogenbroeck J, Vellenga E, Bradley-Garelik MB, Zhu C, Hochhaus A.

    Blood. 2012 Feb 2;119(5):1123-9. Epub 2011 Dec 9.

    PMID:
    22160483
    [PubMed - indexed for MEDLINE]
    5.

    A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside.

    McDermott SP, Eppert K, Notta F, Isaac M, Datti A, Al-Awar R, Wrana J, Minden MD, Dick JE.

    Blood. 2012 Feb 2;119(5):1200-7. Epub 2011 Dec 9.

    PMID:
    22160482
    [PubMed - indexed for MEDLINE]
    6.

    Leukemic transformation of anaplastic large-cell lymphoma.

    Vawda A, Davis J, Vercauteren S.

    Blood. 2011 Oct 6;118(14):3763. No abstract available.

    PMID:
    22073414
    [PubMed - indexed for MEDLINE]
    7.

    Concomitant occurrence of BCR-ABL and JAK2V617F mutation.

    Pieri L, Spolverini A, Scappini B, Occhini U, Birtolo S, Bosi A, Albano F, Fava C, Vannucchi AM.

    Blood. 2011 Sep 22;118(12):3445-6. No abstract available.

    PMID:
    21940831
    [PubMed - indexed for MEDLINE]
    8.

    Key pathways as therapeutic targets.

    Harrison CJ.

    Blood. 2011 Sep 15;118(11):2935-6. No abstract available.

    PMID:
    21921054
    [PubMed - indexed for MEDLINE]
    9.

    Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.

    Nahar R, Ramezani-Rad P, Mossner M, Duy C, Cerchietti L, Geng H, Dovat S, Jumaa H, Ye BH, Melnick A, Müschen M.

    Blood. 2011 Oct 13;118(15):4174-8. Epub 2011 Aug 19.

    PMID:
    21856866
    [PubMed - indexed for MEDLINE]
    10.

    Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.

    Magenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P, Kitko C, Choi S, Yanik G, Frame D, Harris A, Erba H, Kujawski L, Elenitoba-Johnson K, Sanks J, Jones D, Paczesny S, Ferrara J, Levine J, Mineishi S.

    Blood. 2011 Oct 13;118(15):4258-64. Epub 2011 Aug 12.

    PMID:
    21841163
    [PubMed - indexed for MEDLINE]
    11.

    Type I-IFNs control GVHD and GVL responses after transplantation.

    Robb RJ, Kreijveld E, Kuns RD, Wilson YA, Olver SD, Don AL, Raffelt NC, De Weerd NA, Lineburg KE, Varelias A, Markey KA, Koyama M, Clouston AD, Hertzog PJ, Macdonald KP, Hill GR.

    Blood. 2011 Sep 22;118(12):3399-409. Epub 2011 Jun 30.

    PMID:
    21719602
    [PubMed - indexed for MEDLINE]
    12.

    Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.

    Balusu R, Fiskus W, Rao R, Chong DG, Nalluri S, Mudunuru U, Ma H, Chen L, Venkannagari S, Ha K, Abhyankar S, Williams C, McGuirk J, Khoury HJ, Ustun C, Bhalla KN.

    Blood. 2011 Sep 15;118(11):3096-106. Epub 2011 Jun 30.

    PMID:
    21719597
    [PubMed - indexed for MEDLINE]
    13.

    Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses.

    Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, Nakamura S, Seto M.

    Blood. 2011 Sep 22;118(12):3195-204. Epub 2011 Jun 20.

    PMID:
    21690554
    [PubMed - indexed for MEDLINE]
    14.

    PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function.

    Zhang Y, Stehling-Sun S, Lezon-Geyda K, Juneja SC, Coillard L, Chatterjee G, Wuertzer CA, Camargo F, Perkins AS.

    Blood. 2011 Oct 6;118(14):3853-61. Epub 2011 Jun 10.

    PMID:
    21666053
    [PubMed - indexed for MEDLINE]
    15.

    Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.

    Kuchenbauer F, Mah SM, Heuser M, McPherson A, Rüschmann J, Rouhi A, Berg T, Bullinger L, Argiropoulos B, Morin RD, Lai D, Starczynowski DT, Karsan A, Eaves CJ, Watahiki A, Wang Y, Aparicio SA, Ganser A, Krauter J, Döhner H, Döhner K, Marra MA, Camargo FD, Palmqvist L, Buske C, Humphries RK.

    Blood. 2011 Sep 22;118(12):3350-8. Epub 2011 May 31.

    PMID:
    21628414
    [PubMed - indexed for MEDLINE]
    16.

    Survival from childhood cancer in northern England, 1968-2005.

    Basta NO, James PW, Gomez-Pozo B, Craft AW, McNally RJ.

    Br J Cancer. 2011 Oct 25;105(9):1402-8. doi: 10.1038/bjc.2011.341. Epub 2011 Sep 20.

    PMID:
    21934684
    [PubMed - indexed for MEDLINE]
    17.

    Risk of childhood acute lymphoblastic leukaemia following parental occupational exposure to extremely low frequency electromagnetic fields.

    Reid A, Glass DC, Bailey HD, Milne E, de Klerk NH, Downie P, Fritschi L; Aus-ALL Consortium.

    Br J Cancer. 2011 Oct 25;105(9):1409-13. doi: 10.1038/bjc.2011.365. Epub 2011 Sep 13.

    PMID:
    21915123
    [PubMed - indexed for MEDLINE]
    18.

    Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.

    Royle JA, Baade PD, Joske D, Girschik J, Fritschi L.

    Br J Cancer. 2011 Sep 27;105(7):1076-81. doi: 10.1038/bjc.2011.313. Epub 2011 Aug 16.

    PMID:
    21847118
    [PubMed - indexed for MEDLINE]
    19.

    De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.

    Portell CA, Sekeres MA, Rogers HJ, Tiu RV.

    Br J Haematol. 2012 Apr;157(2):266-7. doi: 10.1111/j.1365-2141.2011.08972.x. Epub 2011 Dec 8. No abstract available.

    PMID:
    22150289
    [PubMed - indexed for MEDLINE]
    20.

    Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.

    Tadmor T, Bejar J, Attias D, Polliack A.

    Br J Haematol. 2011 Oct;155(2):135. doi: 10.1111/j.1365-2141.2011.08734.x. No abstract available.

    PMID:
    21973072
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk